Joana Marie Mack
Associate Professor
Also affiliated: Arkansas Children's Hospital (2018–2026); University of Arkansas Medical Center (2017–2026)
Peds Pediatrics, College of Medicine
Research Areas
Biomedical Subjects
Biography and Research Information
OverviewAI-generated summary
Joana Marie Mack investigates the treatment and management of vascular malformations, with a particular focus on pediatric patients. Her research examines the effectiveness and safety of various therapeutic agents, including sirolimus and direct oral anticoagulants like rivaroxaban. Mack has also explored the short-term side effects and patient-reported outcomes associated with bleomycin sclerotherapy, as well as the pharmacokinetics of bleomycin in patients with vascular malformations. Her work extends to analyzing coagulation dynamics during treatment using thromboelastography and investigating early response markers for survival in conditions like hemophagocytic lymphohistiocytosis. Additionally, she has studied the pharmacokinetics of hydroxycarbamide in children with sickle cell anemia. Mack's scholarship metrics include an h-index of 9, with 39 total publications and 233 citations. She has collaborated extensively with researchers at the University of Arkansas for Medical Sciences, including Shelley E. Crary, Divyaswathi Citla Sridhar, Suzanne Saccente, and Gresham T. Richter.
Metrics
- h-index: 9
- Publications: 42
- Citations: 234
Positions
-
Associate Professor publications 2016–2026University of Arkansas for Medical Sciences Peds Pediatrics, College of Medicine Institutional directory
Selected Publications
-
ReInspire: A Phase 2 Study of Mutant-Selective PI3Kα Inhibitor, RLY-2608, in Adults and Children with PIK3CA-Related Overgrowth Spectrum and Malformations Driven by PIK3CA Mutation (2026)
-
Intracranial Hypotension in Pediatric Oncology Patients Following Lumbar Puncture: A Case Series (2025)
-
Creating a Roadmap for Longitudinal Quality Improvement Training in a Pediatric Residency Program (2025)
-
Burnout, Professional Fulfillment, Support, and Protected Time Among Pediatric Fellowship Program Directors (2025)
-
Parental Adverse Childhood Experiences and Health Care Use Among Children With Sickle Cell Disease (2025)
-
Effects of Adoption of Race‐Neutral Predictive Equations on Spirometry Results in Children With Sickle Cell Disease (2025)
-
Sociodemographic Characteristics of Patients Seen at Vascular Anomaly Centers in the United States (2025)
-
Hypercoagulability Evaluation in Pediatric Kidney Transplant Recipients to Optimize Outcomes (2024)
-
How we approach coagulopathy with vascular anomalies (2022)
-
Multimodality treatment of vascular anomalies of the head and neck (2022)
-
Pharmacokinetics of bleomycin sclerotherapy in patients with vascular malformations (2022)
-
How we approach coagulopathy with vascular anomalies. (2021)
-
Analyzing coagulation dynamics during treatment of vascular malformations with thromboelastography (2020)
-
Vascular Anomalies (2019)
-
Effect of sirolimus on coagulopathy of slow‐flow vascular malformations (2019)
Collaboration Network
Top Collaborators
- Effect of sirolimus on coagulopathy of slow‐flow vascular malformations
- Effectiveness and Safety of Treatment with Direct Oral Anticoagulant Rivaroxaban in Patients with Slow-Flow Vascular Malformations: A Case Series
- Short‐term side effects and patient‐reported outcomes of bleomycin sclerotherapy in vascular malformations
- Analyzing coagulation dynamics during treatment of vascular malformations with thromboelastography
- Pharmacokinetics of bleomycin sclerotherapy in patients with vascular malformations
Showing 5 of 11 shared publications
- Effect of sirolimus on coagulopathy of slow‐flow vascular malformations
- Effectiveness and Safety of Treatment with Direct Oral Anticoagulant Rivaroxaban in Patients with Slow-Flow Vascular Malformations: A Case Series
- Short‐term side effects and patient‐reported outcomes of bleomycin sclerotherapy in vascular malformations
- Analyzing coagulation dynamics during treatment of vascular malformations with thromboelastography
- Pharmacokinetics of bleomycin sclerotherapy in patients with vascular malformations
Showing 5 of 7 shared publications
- Pharmacokinetics of bleomycin sclerotherapy in patients with vascular malformations
- Hydroxycarbamide in children with sickle cell anaemia after first‐dose vs. chronic therapy: pharmacokinetics and predictive models for drug exposure
- Pharmacokinetics in Children with Sickle Cell Anemia Following Single Dose Versus Chronic Treatment with Hydroxyurea
- Hydroxycarbamide in children with sickle cell anaemia after first‐dose vs. chronic therapy: pharmacokinetics and predictive models for drug exposure
- Pharmacokinetics in Children with Sickle Cell Anemia Following Single Dose Versus Chronic Treatment with Hydroxyurea
- Hydroxycarbamide in children with sickle cell anaemia after first‐dose vs. chronic therapy: pharmacokinetics and predictive models for drug exposure
- Pharmacokinetics in Children with Sickle Cell Anemia Following Single Dose Versus Chronic Treatment with Hydroxyurea
- Hydroxycarbamide in children with sickle cell anaemia after first‐dose vs. chronic therapy: pharmacokinetics and predictive models for drug exposure
- Pharmacokinetics in Children with Sickle Cell Anemia Following Single Dose Versus Chronic Treatment with Hydroxyurea
- Hydroxycarbamide in children with sickle cell anaemia after first‐dose vs. chronic therapy: pharmacokinetics and predictive models for drug exposure
- Pharmacokinetics in Children with Sickle Cell Anemia Following Single Dose Versus Chronic Treatment with Hydroxyurea
- Hydroxycarbamide in children with sickle cell anaemia after first‐dose vs. chronic therapy: pharmacokinetics and predictive models for drug exposure
- Pharmacokinetics in Children with Sickle Cell Anemia Following Single Dose Versus Chronic Treatment with Hydroxyurea
- Hydroxycarbamide in children with sickle cell anaemia after first‐dose vs. chronic therapy: pharmacokinetics and predictive models for drug exposure
- Pharmacokinetics in Children with Sickle Cell Anemia Following Single Dose Versus Chronic Treatment with Hydroxyurea
- Hydroxycarbamide in children with sickle cell anaemia after first‐dose vs. chronic therapy: pharmacokinetics and predictive models for drug exposure
- Pharmacokinetics in Children with Sickle Cell Anemia Following Single Dose Versus Chronic Treatment with Hydroxyurea
- Short‐term side effects and patient‐reported outcomes of bleomycin sclerotherapy in vascular malformations
- Intracranial Hypotension in Pediatric Oncology Patients Following Lumbar Puncture: A Case Series
- Effect of sirolimus on coagulopathy of slow‐flow vascular malformations
- Analyzing coagulation dynamics during treatment of vascular malformations with thromboelastography
- Analyzing coagulation dynamics during treatment of vascular malformations with thromboelastography
- Pharmacokinetics of bleomycin sclerotherapy in patients with vascular malformations
- Analyzing coagulation dynamics during treatment of vascular malformations with thromboelastography
- Parental Adverse Childhood Experiences and Health Care Use Among Children With Sickle Cell Disease
- Analyzing coagulation dynamics during treatment of vascular malformations with thromboelastography
- Vascular Anomalies
Similar Researchers
Based on overlapping research topics